Biblio

Found 61 results
[ Author(Desc)] Keyword Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
J. Badiee, Moore, D. J., J Atkinson, H., Vaida, F., Gerard, M., Duarte, N. A., Franklin, D., Gouaux, B., J McCutchan, A., Heaton, R. K., McArthur, J., Morgello, S., Simpson, D., Collier, A., Marra, C. M., Gelman, B., Clifford, D., and Grant, I., Lifetime suicidal ideation and attempt are common among HIV+ individuals., J Affect Disord, vol. 136, no. 3, pp. 993-9, 2012.
V. Venkata Ra Bandaru, Mielke, M. M., Sacktor, N., McArthur, J. C., Grant, I., Letendre, S., Chang, L., Wojna, V., Pardo, C., Calabresi, P., Munsaka, S., and Haughey, N. J., A lipid storage-like disorder contributes to cognitive decline in HIV-infected subjects., Neurology, vol. 81, no. 17, pp. 1492-9, 2013.
B. M. Best, Koopmans, P. P., Letendre, S. L., Capparelli, E. V., Rossi, S. S., Clifford, D. B., Collier, A. C., Gelman, B. B., Mbeo, G., J McCutchan, A., Simpson, D. M., Haubrich, R., Ellis, R., and Grant, I., Efavirenz concentrations in CSF exceed IC50 for wild-type HIV., J Antimicrob Chemother, vol. 66, no. 2, pp. 354-7, 2011.
B. M. Best, Letendre, S. L., Brigid, E., Clifford, D. B., Collier, A. C., Gelman, B. B., McArthur, J. C., J McCutchan, A., Simpson, D. M., Ellis, R., Capparelli, E. V., and Grant, I., Low atazanavir concentrations in cerebrospinal fluid., AIDS, vol. 23, no. 1, pp. 83-7, 2009.
B. M. Best, Letendre, S. L., Koopmans, P., Rossi, S. S., Clifford, D. B., Collier, A. C., Gelman, B. B., Marra, C. M., McArthur, J. C., J McCutchan, A., Morgello, S., Simpson, D. M., Capparelli, E. V., Ellis, R. J., and Grant, I., Low cerebrospinal fluid concentrations of the nucleotide HIV reverse transcriptase inhibitor, tenofovir., J Acquir Immune Defic Syndr, vol. 59, no. 4, pp. 376-81, 2012.
A. R. Bharti, Letendre, S. L., Wolfson, T., Clifford, D., Collier, A. C., Gelman, B., McArthur, J., Marra, C., McCutchan, A., Morgello, S., Simpson, D., Ellis, R. J., and Grant, I., Clinical variables identify seronegative HCV co-infection in HIV-infected individuals., J Clin Virol, vol. 52, no. 4, pp. 328-32, 2011.
B. Biswas, Spitznagel, E., Collier, A. C., Gelman, B. B., McArthur, J. C., Morgello, S., McCutchan, J. A., and Clifford, D. B., Characterizing HIV medication adherence for virologic success among individuals living with HIV/AIDS: Experience with the CNS HIV Antiretroviral Therapy Effects Research (CHARTER) cohort., J HIV AIDS Soc Serv, vol. 13, no. 1, pp. 8-25, 2014.
K. Blackstone, Moore, D. J., Heaton, R. K., Franklin, D. R., Woods, S. P., Clifford, D. B., Collier, A. C., Marra, C. M., Gelman, B. B., McArthur, J. C., Morgello, S., Simpson, D. M., Rivera-Mindt, M., Deutsch, R., Ellis, R. J., J Atkinson, H., and Grant, I., Diagnosing symptomatic HIV-associated neurocognitive disorders: self-report versus performance-based assessment of everyday functioning., J Int Neuropsychol Soc, vol. 18, no. 1, pp. 79-88, 2012.
K. Blackstone, Moore, D. J., Franklin, D. R., Clifford, D. B., Collier, A. C., Marra, C. M., Gelman, B. B., McArthur, J. C., Morgello, S., Simpson, D. M., Ellis, R. J., Atkinson, J. H., Grant, I., and Heaton, R. K., Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings., Clin Neuropsychol, vol. 26, no. 6, pp. 894-908, 2012.
T. H. Burdo, Weiffenbach, A., Woods, S. P., Letendre, S., Ellis, R. J., and Williams, K. C., Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infection., AIDS, vol. 27, no. 9, pp. 1387-95, 2013.
D. A. Byrd, Fellows, R. P., Morgello, S., Franklin, D., Heaton, R. K., Deutsch, R., J Atkinson, H., Clifford, D. B., Collier, A. C., Marra, C. M., Gelman, B., J McCutchan, A., Duarte, N. A., Simpson, D. M., McArthur, J., and Grant, I., Neurocognitive impact of substance use in HIV infection., J Acquir Immune Defic Syndr, vol. 58, no. 2, pp. 154-62, 2011.
C
J. Yong Choi, Hightower, G. K., Wong, J. K., Heaton, R., Woods, S., Grant, I., Marcotte, T. D., Ellis, R. J., Letendre, S. L., Collier, A. C., Marra, C. M., Clifford, D. B., Gelman, B. B., McArthur, J. C., Morgello, S., Simpson, D. M., J McCutchan, A., Richman, D. D., and Smith, D. M., Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat., J Neurovirol, vol. 18, no. 2, pp. 81-90, 2012.
D. B. Clifford, Vaida, F., Kao, Y. - T., Franklin, D. R., Letendre, S. L., Collier, A. C., Marra, C. M., Gelman, B. B., McArthur, J. C., Morgello, S., Simpson, D. M., Grant, I., and Heaton, R. K., Absence of neurocognitive effect of hepatitis C infection in HIV-coinfected people., Neurology, vol. 84, no. 3, pp. 241-50, 2015.
D. Croteau, Letendre, S., Best, B. M., Rossi, S. S., Ellis, R. J., Clifford, D. B., Collier, A. C., Gelman, B. B., Marra, C. M., McArthur, J., J McCutchan, A., Morgello, S., Simpson, D. M., Way, L., Capparelli, E., and Grant, I., Therapeutic amprenavir concentrations in cerebrospinal fluid., Antimicrob Agents Chemother, vol. 56, no. 4, pp. 1985-9, 2012.
D. Croteau, Best, B. M., Letendre, S., Rossi, S. S., Ellis, R. J., Clifford, D. B., Collier, A. C., Gelman, B. B., McArthur, J. C., McCutchan, J. Allen, Morgello, S., and Grant, I., Lower than expected maraviroc concentrations in cerebrospinal fluid exceed the wild-type CC chemokine receptor 5-tropic HIV-1 50% inhibitory concentration., AIDS, vol. 26, no. 7, pp. 890-3, 2012.
D. Croteau, Rossi, S. S., Best, B. M., Capparelli, E., Ellis, R. J., Clifford, D. B., Collier, A. C., Gelman, B. B., Marra, C. M., McArthur, J., J McCutchan, A., Morgello, S., Simpson, D. M., Grant, I., and Letendre, S., Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentration., J Antimicrob Chemother, vol. 68, no. 3, pp. 684-9, 2013.
D. Croteau, Letendre, S., Best, B. M., Ellis, R. J., Breidinger, S., Clifford, D., Collier, A., Gelman, B., Marra, C., Mbeo, G., McCutchan, A., Morgello, S., Simpson, D., Way, L., Vaida, F., Ueland, S., Capparelli, E., and Grant, I., Total raltegravir concentrations in cerebrospinal fluid exceed the 50-percent inhibitory concentration for wild-type HIV-1., Antimicrob Agents Chemother, vol. 54, no. 12, pp. 5156-60, 2010.
L. A. Cysique, Franklin, D., Abramson, I., Ellis, R. J., Letendre, S., Collier, A., Clifford, D., Gelman, B., McArthur, J., Morgello, S., Simpson, D., J McCutchan, A., Grant, I., and Heaton, R. K., Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change., J Clin Exp Neuropsychol, vol. 33, no. 5, pp. 505-22, 2011.

Pages